# S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

> **NCT00014144** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 31 (actual)

## Conditions studied

- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- Urethral Cancer

## Interventions

- **DRUG:** gefitinib

## Key facts

- **NCT ID:** NCT00014144
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2003-05
- **Final completion:** 2007-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014144, "S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00014144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*